A cancer expert who helped bring radiation therapy to Bermuda has been invited to speak at a conference in Canada.

Chris Fosker, clinical director and radiation oncologist at Bermuda Cancer and Health Centre, will speak about the cancer control challenges in small island nations at the Global Cancer Control event.

A BCHC spokeswoman said: “Dr Fosker will focus on the collaborative business model that brought radiation therapy to Bermuda which can benefit approximately 200 local cancer patients each year.”

She added: “Dr Fosker will be one of three presenting an ‘in-café session’ on the challenges of cancer control in small island nations.”

The spokeswoman said the Global Cancer Control: Creating the Future conference focuses on innovation and next generation of approaches to global cancer control.

She said: “This conference boast a faculty of over 75 specialists who will map the current state and explore future potential for improved cancer control with a focus on cancer care equity, next-generation strategies and capitalisation on millennial values.

“Keynote addresses by global leaders, workshops, panel discussions, rapid-fire posters, and ‘in-café’ sessions are designed to engage cancer, global health, technology and education experts, as well as political and civil society leaders to identify opportunities for innovation and collaboration to accelerate the progress against cancer globally and to place a focus on cancer control firmly on the global development agenda.”

The spokeswoman explained that Dr Fosker was the “clinical lead” of the project that brought radiation therapy to Bermuda in May last year.

Dr Fosker obtained his medical degree from the University of Leeds in the UK in 2003.

He became a Member of the Royal College of Physicians in 2006 and a Fellow of the Royal College of Radiologists in the UK in 2011.

Dr Fosker completed a Clinical Fellowship at the University of Toronto in 2012 and was awarded the RS Bush Award for Academic Excellence as a Radiation Oncology Fellow.

He is also a consultant clinical oncologist with Bermuda Hospitals Board, an affiliate of the Dana-Farber Cancer Institute and a consultant at the Brigham and Women’s Hospital in Boston.

The conference at the Princess Margaret Cancer Centre at the University Health Network and the Dalla Lana School of Public Health at the University of Toronto, Canada, started today and ends on Saturday.